Cannabidiol in the treatment of Refractory Overactive Bladder: cases report (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorPitliuk, Rubens-
Autor(es): dc.contributor.authorCzeresnia, Carlos Eduardo-
Autor(es): dc.contributor.authorCoelho, Christina Morotomi Funatsu-
Autor(es): dc.contributor.authorLorenzetti, Miriam Dambros-
Autor(es): dc.contributor.authorFucci, Tatyanny Paula Pinto da Costa Santos-
Data de aceite: dc.date.accessioned2022-01-25T12:49:38Z-
Data de disponibilização: dc.date.available2022-01-25T12:49:38Z-
Data de envio: dc.date.issued2022-01-10-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/645161-
Resumo: dc.description.abstractThis observational study evaluated the effect of Cannabidiol Oil with 0.3% Tetrahydrocannabinol: Full Spectrum that is sublingual, in the symptoms of patients diagnosed with Refractory Overactive Bladder Syndrome. Patients were clinically evaluated and with a validated questionnaire for Portuguese language before and 4 weeks after treatment. The drug dosage was 0.25 mL/day (12.5 mg/day) in the first week, 0.50 mL/day (25 mg/day) in the second, 0.75 mL/day (37.5 mg/day) in the third and 1st week. ml (50 mg/day) in the fourth week (given in the evening, single dose). The study included nine patients who were already in clinical follow-up and received first-line treatment for Overactive Bladder Syndrome with partial or no response (drug and behavioral treatment). The data obtained using the questionnaire showed a significant improvement in all patients (more than 50% reduction in nocturia episodes). Adverse effects were mild and affected only two patients.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectBEXIGA URINÁRIApt_BR
Título: dc.titleCannabidiol in the treatment of Refractory Overactive Bladder: cases report (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais